Literature DB >> 27161396

Thyroid Cancer-Specific Quality of Life and Health-Related Quality of Life in Young Adult Thyroid Cancer Survivors.

Melanie Goldfarb1, Jacqueline Casillas2.   

Abstract

BACKGROUND: There is a lack of health-related quality of life (HRQOL) research in thyroid cancer (TC) survivors, especially young adults (YAs). This study aims to assess the socio-demographic and clinical factors that most influence TC-specific QOL domains and estimate the impact of different health conditions on HRQOL in a large cohort of YA TC survivors.
METHODS: TC survivors ≥17 years of age were recruited through the thyroid cancer survivor (ThyCa) Web site. Mean scores for the seven domains and six items of THYCA-QoL, MCS and PCS of SF-12v1, and derived SF-6D were compared between factors as well as age groups (YA: 17-39 years, adult ≥40 years), and to the normal population. Regression analyses estimated the relationship between the socio-demographic, clinical, and THYCA-QoL measures and HRQOL in YAs only.
RESULTS: Of 1028 survivors, 277 (27%) were YAs. Most YAs were female (93.5%), white (86.6%), insured (96.8%), married or in a stable relationship (69%), and listed a comorbidity (43.7%); all reported their entire thyroid had been removed. Average survivorship time was 46.2 months (SD = 51.0). Almost every socio-demographic and clinical factor significantly influenced one or more domain of THYCA-QoL in both YAs and older adults. In both groups, a higher level of education, female sex, unemployment, and having a comorbidity resulted in significantly higher THYCA-QoL scores (more complaints) and lower SF-6D scores (lower HRQOL; p < 0.05). Current YAs had less neuromuscular, voice, sympathetic, and throat/mouth complaints but more grievances involving their scar, headaches, anxiety, and overall psychological state (p < 0.05). The average SF-6D for YAs was 0.70 (SD = 0.13), which was similar to the older adults but significantly different from the normal age-matched population in females (p < 0.01). All THYCA-QoL domains were strongly associated with a lower HRQOL (adj R(2) > 0.5) in YAs. The simplest, best regression model (adj R(2) = 0.53) in YAs included neuromuscular, concentration, and anxiety complaints, as well as having a comorbidity predicting lower HRQOL.
CONCLUSION: TC-specific QOL is significantly influenced by many socio-demographic and clinical factors. HRQOL is lower in female YA TC survivors compared with the normal age-matched population. Neuromuscular, concentration, and anxiety complaints had the greatest impact on HRQOL in YA TC survivors.

Entities:  

Mesh:

Year:  2016        PMID: 27161396     DOI: 10.1089/thy.2015.0589

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  14 in total

1.  Papillary Thyroid Cancer: The Good and Bad of the "Good Cancer".

Authors:  Reese W Randle; Norah M Bushman; Jason Orne; Courtney J Balentine; Elizabeth Wendt; Megan Saucke; Susan C Pitt; Cameron L Macdonald; Nadine P Connor; Rebecca S Sippel
Journal:  Thyroid       Date:  2017-06-12       Impact factor: 6.568

Review 2.  Transoral thyroid and parathyroid surgery via the vestibular approach-a 2020 update.

Authors:  Jonathon O Russell; Zeyad T Sahli; Mohammad Shaear; Christopher Razavi; Khalid Ali; Ralph P Tufano
Journal:  Gland Surg       Date:  2020-04

3.  The Influence of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer: A Qualitative Study.

Authors:  Susan C Pitt; Megan C Saucke; Benjamin R Roman; Stewart C Alexander; Corrine I Voils
Journal:  Thyroid       Date:  2021-11-26       Impact factor: 6.568

4.  Study on Changes in Immune Function After Microwave Ablation of Papillary Thyroid Microcarcinoma.

Authors:  Ting Wu; Guo-Qing Sui; Deng-Ke Teng; Qiang Luo; Hui Wang; Yuan-Qiang Lin
Journal:  Cancer Manag Res       Date:  2022-09-21       Impact factor: 3.602

5.  Patient-Reported Quality-of-Life Outcome Measures in the Thyroid Cancer Population.

Authors:  Eve M Roth; Carrie C Lubitz; John Shannon Swan; Benjamin C James
Journal:  Thyroid       Date:  2020-05-14       Impact factor: 6.568

6.  Endoscopic cephalic access thyroid surgery (EndoCATS) using the retroauricular approach - a single centre retrospective data analysis.

Authors:  Thomas von Ahnen; Ulrich Wirth; Martin von Ahnen; Julia Kroenke; Peter Busch; Hans-Martin Schardey; Stefan Schopf
Journal:  Surg Endosc       Date:  2021-01-11       Impact factor: 4.584

7.  Patient Eligibility for Transoral Endocrine Surgery Procedures in the United States.

Authors:  Raymon H Grogan; Insoo Suh; Kate Chomsky-Higgins; Salman Alsafran; Elya Vasiliou; Christopher R Razavi; Lena W Chen; Ralph P Tufano; Quan-Yang Duh; Peter Angelos; Jonathon O Russell
Journal:  JAMA Netw Open       Date:  2019-05-03

Review 8.  Minimally invasive and remote-access thyroid surgery in the era of the 2015 American Thyroid Association guidelines.

Authors:  Jonathon O Russell; Salem I Noureldine; Mai G Al Khadem; Ralph P Tufano
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-11-14

9.  Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation.

Authors:  Jonghwa Ahn; Min Ji Jeon; Eyun Song; Tae Yong Kim; Won Bae Kim; Young Kee Shong; Won Gu Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2020-03

10.  Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.

Authors:  Susan C Pitt; Megan C Saucke; Elizabeth M Wendt; David F Schneider; Jason Orne; Cameron L Macdonald; Nadine P Connor; Rebecca S Sippel
Journal:  Thyroid       Date:  2020-11-04       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.